Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Dose Fractionation of Testosterone Cypionate on Hematocrit in Transgender Men with Erythrocytosis Secondary to Testosterone Use.

NCT05487794 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT05487794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05487794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Dose Fractionation of Testosterone Cypionate on Hematocrit in Transgender Men with Erythrocytosis Secondary to Testosterone Use.
Lead sponsor
University of Sao Paulo
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2022
Completion date
December 17, 2024
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematologic diseases, testosterone, transsexualism